|
Fuzheng Yiliu Granule (扶正抑瘤颗粒) inhibits the growth of hepatocellular cancer by regulating immune function and inducing apoptosis in vivo and in vitro |
|
View Full Text View/Add Comment Download reader |
|
KeyWord: |
Author Name | Affiliation | E-mail | Zhi-yun Cao | Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350108, China | | Xu-zheng Chen | Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350108, China | | Lian-ming Liao | Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350108, China | | Jun Peng | Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350108, China | | Hai-xia Hu | Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350108, China | | Zhi-zhen Liu | Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350108, China | | Jian Du | Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350108, China | dujian@fjtcm.edu.cn |
|
Hits: 1167 |
Download times: 883 |
Abstract: |
Objective To study the inhibitory effect of Fuzheng Yiliu Granule (扶正抑瘤颗粒, FYG) on hepatocellular cancer (HCC) and investigate the mechanism mediating its bioactivity. |
Close |
|
|
|